Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555965 · ClinicalTrials.gov registry record
STXBP1 and SYNGAP1 Related Disorders Natural History Study
A clinical trial of Genetic Disease and STXBP1 Encephalopathy With Epilepsy, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 600
- Enrollment target
- 5
- Study locations
NCT06555965 is a study of Genetic Disease and STXBP1 Encephalopathy With Epilepsy that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 600 participants, below the 2,541-participant average among 30 other Genetic Disease trials with a reported enrollment target (76% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT06555965, a study of Genetic Disease and STXBP1 Encephalopathy With Epilepsy, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to find out more about STXBP1 and SYNGAP1 related disorders. The information gathered by this study will be used to prepare for clinical treatment trials. The primary objective of the study is to better define and outline the clinical spectrum of STXBP1 and SYNGAP1 through detailed developmental, seizure, and quality of life assessments as an extension of routine clinical care.
Conditions Studied
Interventions
- OTHER Non-interventional study
Study Locations (5)
California
- Stanford Medicine Children's Health - Palo Alto
Colorado
- Children's Hospital Colorado - Aurora
New York
- Weill Cornell Medicine - New York
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2028-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06555965
The ClinicalTrials.gov registry entry for NCT06555965 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,541-participant average among 30 other Genetic Disease trials with a reported enrollment target (76% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Non-interventional study is the first listed.
NCT06555965 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, New York.
Frequently Asked Questions
What is clinical trial NCT06555965 about?
NCT06555965 is a clinical study titled "STXBP1 and SYNGAP1 Related Disorders Natural History Study". The purpose of this study is to find out more about STXBP1 and SYNGAP1 related disorders. The information gathered by this study will be used to prepare for clinical treatment trials. The primary objective of the study is to better define and outline the clinical spectrum of STXBP1 and SYNGAP1 throu...
What is the current status of trial NCT06555965?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2023-08-30. Estimated completion is 2028-12-30.
What conditions does trial NCT06555965 study?
This clinical trial studies the following conditions: Genetic Disease, STXBP1 Encephalopathy With Epilepsy, SYNGAP1-Related Intellectual Disability.
What interventions are being tested in trial NCT06555965?
The interventions under investigation include: Non-interventional study (OTHER).
Who is sponsoring clinical trial NCT06555965?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06555965 being conducted?
This trial has 5 study locations across California, Colorado, New York, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.